Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Novo Nordisk continues to investigate stem cell therapies for chronic diseases and Kite expands manufacturing capability

This week: FDA accepts IND for gene-edited sickle cell therapy and severe hemophilia A patients targeted in phase I/II study.

Go to the profile of RegMedNet
May 17, 2018
0
0

Please sign in or register for FREE

No comments yet.